Suppr超能文献

自身免疫性 CD4 T 细胞微调 TCF1 表达以维持功能并在糖尿病期间持续抗原暴露下存活。

Autoimmune CD4 T cells fine-tune TCF1 expression to maintain function and survive persistent antigen exposure during diabetes.

机构信息

Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT 84112, USA.

Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT 84112, USA.

出版信息

Immunity. 2024 Nov 12;57(11):2583-2596.e6. doi: 10.1016/j.immuni.2024.09.016. Epub 2024 Oct 12.

Abstract

Self-reactive T cells experience chronic antigen exposure but do not exhibit signs of exhaustion. Here, we investigated the mechanisms for sustained, functioning autoimmune CD4 T cells despite chronic stimulation. Examination of T cell priming showed that CD4 T cells activated in the absence of infectious signals retained TCF1 expression. At later time points and during blockade of new T cell recruitment, most islet-infiltrating autoimmune CD4 T cells were TCF1, although expression was reduced on a per T cell basis. The Tcf7 locus was epigenetically modified in circulating autoimmune CD4 T cells, suggesting a pre-programmed de novo methylation of the locus in early stages of autoimmune CD4 T cell differentiation. This mirrored the epigenetic profile of recently recruited CD4CD62L T cells in the pancreas. Collectively, these data reveal a unique environment during autoimmune CD4 T cell priming that allows T cells to fine-tune TCF1 expression and maintain long-term survival and function.

摘要

自身反应性 T 细胞经历慢性抗原暴露,但没有表现出衰竭的迹象。在这里,我们研究了尽管持续受到刺激,但仍能维持自身免疫性 CD4 T 细胞持续功能的机制。对 T 细胞启动的检查表明,在没有感染信号的情况下激活的 CD4 T 细胞保留了 TCF1 的表达。在稍后的时间点和阻断新 T 细胞募集期间,大多数胰岛浸润的自身免疫性 CD4 T 细胞是 TCF1,尽管每个 T 细胞的表达都减少了。循环自身免疫性 CD4 T 细胞中 Tcf7 基因座发生了表观遗传修饰,提示在自身免疫性 CD4 T 细胞分化的早期阶段,该基因座发生了新的从头甲基化。这反映了最近在胰腺中募集的 CD4CD62L T 细胞的表观遗传特征。总的来说,这些数据揭示了自身免疫性 CD4 T 细胞启动过程中的一个独特环境,使 T 细胞能够微调 TCF1 的表达并维持长期存活和功能。

相似文献

1
Autoimmune CD4 T cells fine-tune TCF1 expression to maintain function and survive persistent antigen exposure during diabetes.
Immunity. 2024 Nov 12;57(11):2583-2596.e6. doi: 10.1016/j.immuni.2024.09.016. Epub 2024 Oct 12.
2
How do autoimmune CD4 T cells handle exhaustion?
Trends Immunol. 2024 Dec;45(12):922-924. doi: 10.1016/j.it.2024.11.004. Epub 2024 Nov 27.
3
T Cell Factor 1 Suppresses CD103+ Lung Tissue-Resident Memory T Cell Development.
Cell Rep. 2020 Apr 7;31(1):107484. doi: 10.1016/j.celrep.2020.03.048.
4
B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
J Immunol. 2004 Sep 15;173(6):3631-9. doi: 10.4049/jimmunol.173.6.3631.
5
Central memory CD8 T cells derive from stem-like Tcf7 effector cells in the absence of cytotoxic differentiation.
Immunity. 2020 Nov 17;53(5):985-1000.e11. doi: 10.1016/j.immuni.2020.09.005. Epub 2020 Oct 30.
6
Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state.
Immunity. 2024 Nov 12;57(11):2565-2582.e6. doi: 10.1016/j.immuni.2024.09.017. Epub 2024 Oct 23.
7
TCF1 links GIPR signaling to the control of beta cell function and survival.
Nat Med. 2016 Jan;22(1):84-90. doi: 10.1038/nm.3997. Epub 2015 Dec 7.
10
De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation.
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10631-6. doi: 10.1073/pnas.1524490113. Epub 2016 Aug 31.

引用本文的文献

1
Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?
Trends Immunol. 2025 Jul 23. doi: 10.1016/j.it.2025.07.001.
2
Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy.
Cell Mol Immunol. 2025 Jul 10. doi: 10.1038/s41423-025-01321-7.
3
Immune regeneration: implications for cancer immunotherapy and beyond.
J Clin Invest. 2025 Jul 1;135(13). doi: 10.1172/JCI192731.
4
Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians.
Diabetes Obes Metab. 2025 May 15. doi: 10.1111/dom.16460.
5
UTX Epigenetically Imposes a Cytolytic Effector Program in Autoreactive Stem-like CD8+ T cell Progenitors.
bioRxiv. 2024 Dec 20:2024.12.12.628206. doi: 10.1101/2024.12.12.628206.

本文引用的文献

1
Reversible, tunable epigenetic silencing of TCF1 generates flexibility in the T cell memory decision.
Immunity. 2024 Feb 13;57(2):271-286.e13. doi: 10.1016/j.immuni.2023.12.006. Epub 2024 Jan 31.
2
CD4 T cell immunity is dependent on an intrinsic stem-like program.
Nat Immunol. 2024 Jan;25(1):66-76. doi: 10.1038/s41590-023-01682-z. Epub 2024 Jan 2.
3
Stem-like CD4 T cells in perivascular tertiary lymphoid structures sustain autoimmune vasculitis.
Sci Transl Med. 2023 Sep 6;15(712):eadh0380. doi: 10.1126/scitranslmed.adh0380.
4
Human immune phenotyping reveals accelerated aging in type 1 diabetes.
JCI Insight. 2023 Sep 8;8(17):e170767. doi: 10.1172/jci.insight.170767.
5
Tet2 coordinates with Foxo1 and Runx1 to balance T follicular helper cell and T helper 1 cell differentiation.
Sci Adv. 2022 Jun 17;8(24):eabm4982. doi: 10.1126/sciadv.abm4982. Epub 2022 Jun 15.
6
BCL6-dependent TCF-1 progenitor cells maintain effector and helper CD4 T cell responses to persistent antigen.
Immunity. 2022 Jul 12;55(7):1200-1215.e6. doi: 10.1016/j.immuni.2022.05.003. Epub 2022 May 27.
7
Autoreactive CD8 T cells are restrained by an exhaustion-like program that is maintained by LAG3.
Nat Immunol. 2022 Jun;23(6):868-877. doi: 10.1038/s41590-022-01210-5. Epub 2022 May 26.
8
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.
J Exp Med. 2022 Jun 6;219(6). doi: 10.1084/jem.20210749. Epub 2022 Apr 26.
9
A dormant T-cell population with autoimmune potential exhibits low self-reactivity and infiltrates islets in type 1 diabetes.
Eur J Immunol. 2022 Jul;52(7):1158-1170. doi: 10.1002/eji.202149690. Epub 2022 Apr 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验